These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33442108)

  • 21. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
    Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
    Diabetes Res Clin Pract; 2017 Aug; 130():121-129. PubMed ID: 28602812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
    Peene B; D'Hooge D; Vandebrouck T; Mathieu C
    Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
    de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
    BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study.
    Rauh SP; Rutters F; Thorsted BL; Wolden ML; Nijpels G; van der Heijden AA; Walraven I; Elders PJ; Heymans MW; Dekker JM
    BMJ Open; 2016 Sep; 6(9):e012793. PubMed ID: 27645557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
    Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP;
    Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures.
    Jensen MH; Vestergaard P
    Osteoporos Int; 2019 Aug; 30(8):1663-1670. PubMed ID: 31129687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study.
    Sullivan SD; Freemantle N; Gupta RA; Wu J; Nicholls CJ; Westerbacka J; Bailey TS
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00306. PubMed ID: 34807513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nocturnal Hypoglycaemia in Patients with Diabetes Mellitus: Database Analysis of a Cohort Using Telemedicine Support for Self-Monitoring of Blood Glucose over a 10-Year-Long Period.
    Jermendy G; Kecskes A; Nagy A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33672913
    [No Abstract]   [Full Text] [Related]  

  • 31. Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials.
    DeVries JH; Bailey TS; Bhargava A; Gerety G; Gumprecht J; Heller S; Lane W; Wysham CH; Zinman B; Bak BA; Hachmann-Nielsen E; Philis-Tsimikas A
    Diabetes Obes Metab; 2019 Mar; 21(3):622-630. PubMed ID: 30362250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study.
    Aronson R; Goldenberg R; Boras D; Skovgaard R; Bajaj H
    Can J Diabetes; 2018 Feb; 42(1):11-17. PubMed ID: 28528246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
    Agesen RM; Alibegovic AC; Andersen HU; Beck-Nielsen H; Gustenhoff P; Hansen TK; Hedetoft C; Jensen T; Juhl CB; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    BMC Endocr Disord; 2019 Jul; 19(1):78. PubMed ID: 31337371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study.
    Lane W; Faurby M; Husemoen LLN; Markovich DL; Rathor N; De Block C
    Diabetes Ther; 2021 Dec; 12(12):3067-3077. PubMed ID: 34637112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.
    Brod M; Rana A; Barnett AH
    Curr Med Res Opin; 2012 Dec; 28(12):1947-58. PubMed ID: 23150950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 diabetes patients' views on prevention of hypoglycaemia - a mixed methods study investigating self-management issues and self-identified causes of hypoglycaemia.
    Crutzen S; van den Born-Bondt T; Denig P; Taxis K
    BMC Fam Pract; 2021 Jun; 22(1):114. PubMed ID: 34126938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir SA
    Drug Saf; 2009; 32(5):409-18. PubMed ID: 19419235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2.
    Heller SR; DeVries JH; Wysham C; Hansen CT; Hansen MV; Frier BM
    Diabetes Obes Metab; 2019 Jul; 21(7):1634-1641. PubMed ID: 30891886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.